2Van den Bruel A,Thompson MJ,Haj-Hassan T, et al.Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review[J].BMJ,2011,8(342):d3082.
5Marcus N,Mor M,Amir L,et al.Validity of the quick-read C-reac- tive protein test in the prediction of bacterial pneumonia in the pediatricemergency department[J].Eur J Emerg Med, 2008,15(3): 158-161.
6Van der Starre WE,Zunder SM,Vollaard AM,et al.Prognostic value of Pro-adrenomedullin, Procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection[J].Clin Micro- biol Infect,2014,Jul 9. ,.
7Silvestre J,Rebanda J,Lourengo C,et al.Diagnostic accuracy of C- reactive protein and procalcitonin in the early detection of infec- tion after elective coloreetal surgery-a pilot study[J].BMC Infect Dis,2014,14(1):444.
8Travaglino F, Russo V, De Berardinis B,et al.Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea.Results from the VERyfing DYspnea trial[J].Am J Emerg Med,2014,32(4):334-341.
4Kristóf K,Kocsis E,Nagy K.Clinical microbiology of early-onset and late-onset neonatal sepsis,particularly among preterm babies[J].Acta Microbiol Immunol Hung,2009,56(1):21-51.
5Zuppa A A,Calabrese V,D'Andrea V,et al.Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis[J].Minerva Pediatr,2007,59(3):267-274.
6Ramirez-Valdivia J M,Pérez-Molina J J,Locheo-González M,et al.Procalcitonin a marker in the diagnostic of the newborn with systemic infection[J].Rev Med Inst Mex Seguro Soc,2008,46(6):597-602.
7Sasaki K,Fujita I,Hamasaki Y,et al.Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers[J].J Infect Chemother,2002,8 (1):76-80.
8Martin G S,Mannino D M,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-1554.
9Bone RC,Balk RA,Cerra FB. ACCP/SCCM definitions for sepsis and organ failure guidelines for the use of innovative therapies in sepsis[J]. Chest, 1992,101:1644- 1655.
10Joan M. The role of C reactive protein in the evaluation and management of infants with suspected sepsis[J].Adv Neonatal Care,2003,3(1):3 -13.
3Travaglino F, Russo V, De Berardinis B, et al. Thirty and ninety daysmortality predictive value of admission and in-hospital procalci- tonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the verifing dyspnea trim [ J ]. Am J Emer Med, 2014, 32(4) :334-341.
4Bleharski JR, Kiessler V, Buonsanfi C, et al. A role for triggeringreceptor expressed on myeloid cells-1 in host defense during the ear- ly-induced and adaptive phases of the immune response [ J ]. J Im- munol, 2003, 170(12) :3812-3818.
5Gingras MC, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated ~'ith a mature stage of myeloid de- velopment[ J ]. Mol [mmunol, 2002, 38 (8) :817-824.
6Bouchon A, FaccheRi F, Weigand MA, et al. TREM-I amplifies inflammation and is a crucial mediator of septic shock [ J ]. Na- ture, 2001, 410(4) :1103-1107.
7Gihot S, Kolopp-Sarda MN, B6n6 MC, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis [ J ]. J Exp Med, 2004, 200(5) :1419-1426.
8Gibot S, Cravoisy A, Levy B, et al. Sotuble triggering receptor expressed on myeloid ceils and the diagnosis of pneumonia[J]. N Engl J Med, 2004, 350(5) :451-458.
9Richeldi L, Mariani M, Lesi M, et al. Triggering receptor ex-pressed on myeloid cells: role in the diagnosis of lung infections [ J ]. Eur Respir J, 2(104, 24(3):247-250.
10Malady AM, Lowes DA, Galley HF, et al. Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccha- ride-stimulated human neutrophils involves de novo protein syn- thesis C J ]. Clin Vaccine Immunol, 2006, 13 (4) :492-495.
